Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about renal cell carcinoma

Recent news which mentions renal cell carcinoma

Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
Tickers ALKS
Tags General Phase 2 Trial Phase 1 Trial
From Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
Tickers BMY EXEL
Tags Benzinga Health Care Phase 3 Trial
From Benzinga
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer
Tickers AVEO BAYRY
Tags Briefs Penny Stocks General
From Benzinga
Merck's Keytruda Wins European Approval For Post-Surgery Kidney Cancer
Tickers MRK
Tags Biotech MRK News
From Benzinga
EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer
Tickers MRK
Tags European Medicines Agency Briefs renal cell carcinoma
From Benzinga
Bristol Myers Touts 5-Year Kidney Cancer Data For Opdivo-Yervoy Combo Therapy
Tickers BMY PFE
Tags ESMO21 renal cell carcinoma BMY
From Benzinga
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
Tickers BMY EXEL PFE
Tags Health Care Phase 3 Trial General
From Benzinga
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
Tickers BMY EXEL TAK TKPHF
Tags FDA renal cell carcinoma TAK
From Benzinga
Merck's Belzutifan Wins FDA Approval As First Drug For Rare VHL Tumors
Tickers MRK
Tags tumors oncology cancer
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.